Market Overview

Charles River Labs Closes Purchase of Majority Ownership of Vital River

Share:
Related CRL
Jefferies Highlights A Pair Trade In Pharma: Buy ICON, Hold Tight On INC Research
Biotech Stock Roundup: Management Changes at Biogen, Alexion, GILD Files HIV Drug

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has completed its acquisition of a 75% ownership of Vital River, the premier commercial provider of research models and related services in China, and a licensee of Charles River for the last ten years.

Posted-In: News M&A

 

Related Articles (CRL)

View Comments and Join the Discussion!